To Be Precise | GenomeWeb

To Be Precise

Medical institutions across the US are investing in large centers, new technology, and more experts to bring precision medicine — the new personalized medicine — to the clinic, especially to cancer patients, the New York Times reports. While the expectation is that, eventually, every patient will undergo genomic sequencing, "even optimists warn that medicine is a long way from deriving useful information from routine sequencing," the Times says.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.